Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced...
1 insider sale filing on record · latest filing 2026-09-03.
No open-market insider purchases (SEC Form 4 code P) on record for AUTL.